解剖病理學市場規模、佔有率、成長分析、按產品、按應用、按最終用途、按地區 - 行業預測，2025-2032 年

2023年解剖病理市場規模為377.1億美元，從2024年的404.6億美元成長到2032年的703.2億美元，在預測期內（2025-2032年）預計將以7.3%的年複合成長率成長。

由於臨床生物標記擴大用於疾病發展，以加強臨床決策和改善患者治療結果，預計全球解剖病理學市場將出現強勁成長。這種需求正在進一步增加，特別是在印度和中國等開發中國家，基於生物標記的病理測試正在變得越來越普遍，先進技術正在引進。病理檢測設備（包括數位顯微鏡和染色系統）的顯著進步也有助於市場擴張。特別是像 OptraSCAN 這樣的公司正在透過智慧解決方案進行創新，以簡化分析流程。皇家飛利浦和 Ibex Medical Analytics 等合作旨在將人工智慧融入病理學，促進創新並擴大產品系列，確保該行業在整個預測期內持續成長。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 生態系繪圖
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 案例研究
• 技術評估
• 監管環境
• 管道分析
• 疾病流行病學
• 專利分析

解剖病理學市場規模：按產品和服務分類

• 市場概況
• 裝置
  • 玻片染色系統
  • 組織處理系統
  • 細胞處理器
  • 切片機和低溫恒溫器
  • 嵌入系統
  • 蓋拖鞋
  • 其他產品
• 消耗品
  • 抗體
  • 一抗
  • 二抗
  • 試劑套件和試劑
  • 污垢和溶劑
  • 穩定劑
  • 其他套件和試劑
  • 探測
  • 其他消耗品
• 服務
  • 組織病理學服務
  • 細胞病理服務

解剖病理學市場規模：依應用分類

• 市場概況
• 疾病診斷
  • 癌症
  • 乳癌
  • 消化道癌症
  • 肺癌
  • 攝護腺癌
  • 其他癌症
  • 其他疾病
• 醫學調查
• 藥物發現與開發
• 其他

解剖病理學市場規模：依最終用途分類

• 市場概況
• 醫院
• 臨床實驗室
• 診斷實驗室
• 其他

解剖病理學市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• F. Hoffman-LA Roche Ltd.
• Danaher Corporation
• PHC Holdings Corporation
• Abcam Plc.
• Hologic, Inc.
• Agilent Technologies
• Becton, Dickinson And Company
• Sakura Finetek Usa Inc.
• Merck Kgaa
• Bio SB
• Quest Diagnostics Incorporated
• Laboratory Corporation of America Holdings
• Cardinal Health
• NeoGenomics Laboratories, Inc.
• BioGenex
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Siemens AG
• Cell Signaling Technology, Inc.
• PerkinElmer Inc.

結論和建議

Anatomic Pathology Market size was valued at USD 37.71 Billion in 2023 and is poised to grow from USD 40.46 Billion in 2024 to USD 70.32 Billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The global anatomic pathology market is poised for robust growth, driven by the increased utilization of clinical biomarkers for disease pathogenesis, which enhances clinical decision-making and improves patient outcomes. The rising prevalence of biomarker-based pathology tests and advanced technology adoption, particularly in developing nations like India and China, further fuels this demand. Significant advancements in pathology equipment, including digital microscopes and staining systems, are also contributing to market expansion. Notably, companies like OptraSCAN are innovating with intelligent solutions to streamline analysis processes. Collaborations, such as that between Royal Philips and Ibex Medical Analytics, aim to integrate AI into pathology, fostering innovation and broadening product portfolios, thus ensuring continued growth in this sector through the forecast period.

Top-down and bottom-up approaches were used to estimate and validate the size of the Anatomic Pathology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Anatomic Pathology Market Segmental Analysis

Global Anatomic Pathology Market is segmented by product, application, end use and region. Based on product, the market is segmented into instruments, consumables and services. Based on application, the market is segmented into disease diagnostics, medical research, drug discovery and development and others. Based on end use, the market is segmented into hospitals, clinical laboratories, diagnostic laboratories and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Anatomic Pathology Market

The anatomic pathology market is poised for significant growth, primarily driven by the rising incidence of various chronic diseases and evolving consumer lifestyles and dietary habits. Our research indicates that the global population aged 65 and older was approximately 727 million in 2020 and is projected to double to 1.5 billion by 2050. This substantial increase in the elderly demographic is anticipated to generate considerable opportunities for the anatomic pathology market in the near future. As a result, the combination of demographic shifts and the growing burden of chronic conditions will be key factors propelling market expansion throughout the forecast period.

Restraints in the Anatomic Pathology Market

One significant restraint impacting the anatomic pathology market is the limited availability of refurbished anatomic pathology equipment globally. This scarcity poses a challenge, particularly for small and medium-sized hospitals and laboratories that prioritize cost-effectiveness in their investments. As these end users often opt for refurbished equipment to meet their budget constraints, the lack of supply in this segment is anticipated to hinder the overall growth of the anatomic pathology market during the projected period. Therefore, addressing the shortage of affordable, refurbished options is crucial for fostering a more robust market environment.

Market Trends of the Anatomic Pathology Market

The anatomic pathology market is experiencing a notable shift towards advanced technological solutions, driven by the increasing adoption of digital microscopes, staining systems, and gross imaging tools. These innovations offer enhanced accuracy and specificity compared to traditional methods, revolutionizing diagnostic processes. As healthcare providers seek to improve patient outcomes through more reliable and efficient pathology solutions, the demand for sophisticated anatomic pathology equipment is surging. This trend underscores a broader movement towards digitalization and automation in healthcare, presenting lucrative growth opportunities for manufacturers and service providers in the anatomic pathology sector over the next few years.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree Of Competition
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2024
• Pestel Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Assessment
• Regulatory Landscape
• Pipeline Analysis
• Disease Epidemiology
• Patent Analysis

Global Anatomic Pathology Market Size by Product & Services & CAGR (2025-2032)

• Market Overview
• Instruments
  • Slide Staining Systems
  • Tissue Processing Systems
  • Cell Processors
  • Microtomes & Cryostat
  • Embedding Systems
  • Cover Slippers
  • Other Products
• Consumables
  • Antibodies
  • Primary Antibodies
  • Secondary Antibodies
  • Kits And Reagents
  • Stains And Solvents
  • Fixatives
  • Other Kits and Reagents
  • Probes
  • Other Consumables
• Services
  • Histopathology Services
  • Cytopathology Services

Global Anatomic Pathology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Disease Diagnostics
  • Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancers
  • Other Diseases
• Medical Research
• Drug Discovery and Development
• Others

Global Anatomic Pathology Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Clinical Laboratories
• Diagnostic Laboratories
• Others

Global Anatomic Pathology Market Size & CAGR (2025-2032)

• North America (Product & Services, Application, End Use)
  • US
  • Canada
• Europe (Product & Services, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• F. Hoffman-LA Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PHC Holdings Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abcam Plc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson And Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sakura Finetek Usa Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Kgaa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio SB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corporation of America Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoGenomics Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGenex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations